Form 4: BioCardia CEO Peter Altman Acquires 2,750 Shares of Common Stock
SEC Form 4 Filing
BioCardia's President and CEO, Peter Altman, purchased 2,750 shares of the company's common stock at a price of $0.3683 per share on April 19, 2024.
Summary
- On April 19, 2024, Peter Altman, the President and CEO of BioCardia, Inc., acquired 2,750 shares of common stock.
- The purchase price was $0.3683 per share.
- Following the transaction, Altman directly owns 558,697 shares of BioCardia's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive signal, but the document itself is a routine regulatory filing.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider trading activity is closely monitored and can influence investor sentiment. CEO's buying shares is generally seen as a positive sign.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 04/19/2024 | Date of the transaction where Peter Altman acquired 2,750 shares of BioCardia's common stock. |
Keywords
BioCardia, Peter Altman, BCDA, Insider Trading, Stock Acquisition, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.